Cargando…
Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667286/ https://www.ncbi.nlm.nih.gov/pubmed/37971758 http://dx.doi.org/10.1182/blood.2023022676 |
| _version_ | 1785149032145879040 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10667286 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106672862023-11-16 Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. Blood Erratum The American Society of Hematology 2023-11-16 2023-11-16 /pmc/articles/PMC10667286/ /pubmed/37971758 http://dx.doi.org/10.1182/blood.2023022676 Text en © 2023 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Erratum Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title | Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title_full | Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title_fullStr | Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title_full_unstemmed | Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title_short | Jutzi JS, Marneth AE, Ciboddo M, et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood. 2022;140(11):1291-1304. |
| title_sort | jutzi js, marneth ae, ciboddo m, et al. whole-genome crispr screening identifies n-glycosylation as a genetic and therapeutic vulnerability in calr-mutant mpns. blood. 2022;140(11):1291-1304. |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667286/ https://www.ncbi.nlm.nih.gov/pubmed/37971758 http://dx.doi.org/10.1182/blood.2023022676 |